In my opinion, both complementary and necessary, the misinterpretation of landmark scientific breakthroughs equal immediate engagement and funding, and also equal, exaggerated hopes in a new pill. Decades of research has speed up these consequences, and this article may provide a tidy example ( replicated in hundreds of other research timetables), of a single aspect of this landscape, zooming in on the real pace ( of human disease benefits) attempting to overcome unknown complexities relating to a single mutation.
"Cancer drugs are closing in on some of the deadliest mutations"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.